Christopher J. Novosad

Array ( [id] => 7200136 [patent_doc_number] => 20050042227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Megalin-based delivery of therapeutic compounds to the brain and other tissues' [patent_app_type] => utility [patent_app_number] => 10/812849 [patent_app_country] => US [patent_app_date] => 2004-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 41384 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042227.pdf [firstpage_image] =>[orig_patent_app_number] => 10812849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 830186 [patent_doc_number] => 07399740 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-15 [patent_title] => 'Poly-Glu,Tyr for neuroprotective therapy' [patent_app_type] => utility [patent_app_number] => 10/807414 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 28761 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399740.pdf [firstpage_image] =>[orig_patent_app_number] => 10807414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7345535 [patent_doc_number] => 20040247606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Treatment of sinusitis related chronic facial pain and headache with botulinum toxin injections' [patent_app_type] => new [patent_app_number] => 10/793964 [patent_app_country] => US [patent_app_date] => 2004-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5016 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20040247606.pdf [firstpage_image] =>[orig_patent_app_number] => 10793964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7285921 [patent_doc_number] => 20040146532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Agents and methods for treating pain' [patent_app_type] => new [patent_app_number] => 10/791434 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15555 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146532.pdf [firstpage_image] =>[orig_patent_app_number] => 10791434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7316705 [patent_doc_number] => 20040223968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Mammalian monocyte Chemoattractant protein receptors' [patent_app_type] => new [patent_app_number] => 10/791166 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16579 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20040223968.pdf [firstpage_image] =>[orig_patent_app_number] => 10791166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7423112 [patent_doc_number] => 20040265308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Prevention and treatment of amyloidogenic disease' [patent_app_type] => new [patent_app_number] => 10/788666 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 32512 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 39 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265308.pdf [firstpage_image] =>[orig_patent_app_number] => 10788666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7422332 [patent_doc_number] => 20040229285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Serotonin and catecholamine system segment optimization technology' [patent_app_type] => new [patent_app_number] => 10/785158 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5105 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229285.pdf [firstpage_image] =>[orig_patent_app_number] => 10785158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7128058 [patent_doc_number] => 20050059802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Prevention and treatment of amyloidogenic disease' [patent_app_type] => utility [patent_app_number] => 10/777792 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 41001 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059802.pdf [firstpage_image] =>[orig_patent_app_number] => 10777792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596171 [patent_doc_number] => 20060160088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 40 (gpr40)' [patent_app_type] => utility [patent_app_number] => 10/544614 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 33176 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160088.pdf [firstpage_image] =>[orig_patent_app_number] => 10544614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5027980 [patent_doc_number] => 20070269427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Therapeutical Use of Anti-Myelin Associated Glycoprotein (Mag) Antibodies' [patent_app_type] => utility [patent_app_number] => 10/550363 [patent_app_country] => US [patent_app_date] => 2004-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12187 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269427.pdf [firstpage_image] =>[orig_patent_app_number] => 10550363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596170 [patent_doc_number] => 20060160087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Monitoring and treatment of amyotrophic lateral sclerosis' [patent_app_type] => utility [patent_app_number] => 10/544059 [patent_app_country] => US [patent_app_date] => 2004-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 31721 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160087.pdf [firstpage_image] =>[orig_patent_app_number] => 10544059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005047 [patent_doc_number] => 20050170360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Variant neuronal nicotinic alpha-7 receptor and methods of use' [patent_app_type] => utility [patent_app_number] => 10/769085 [patent_app_country] => US [patent_app_date] => 2004-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23485 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20050170360.pdf [firstpage_image] =>[orig_patent_app_number] => 10769085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7345073 [patent_doc_number] => 20040247525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Brain progenitor cell-based assay, and related methods and compositions' [patent_app_type] => new [patent_app_number] => 10/764068 [patent_app_country] => US [patent_app_date] => 2004-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16840 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20040247525.pdf [firstpage_image] =>[orig_patent_app_number] => 10764068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7304222 [patent_doc_number] => 20040115682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Novel scavenger receptor class a protein' [patent_app_type] => new [patent_app_number] => 10/468335 [patent_app_country] => US [patent_app_date] => 2004-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11770 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115682.pdf [firstpage_image] =>[orig_patent_app_number] => 10468335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7456911 [patent_doc_number] => 20040197315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Dopaminergic cell lines stably expressing A53T alpha-synuclein and methods of using same' [patent_app_type] => new [patent_app_number] => 10/737262 [patent_app_country] => US [patent_app_date] => 2003-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15270 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197315.pdf [firstpage_image] =>[orig_patent_app_number] => 10737262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 442507 [patent_doc_number] => 07256002 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-14 [patent_title] => 'Screening for neurotoxic amino acid associated with neurological disorders' [patent_app_type] => utility [patent_app_number] => 10/731411 [patent_app_country] => US [patent_app_date] => 2003-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14709 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/256/07256002.pdf [firstpage_image] =>[orig_patent_app_number] => 10731411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120557 [patent_doc_number] => 20070142272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Neuroprotective activity of activated protein c independent of its anticoagulant activity' [patent_app_type] => utility [patent_app_number] => 10/537545 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16638 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142272.pdf [firstpage_image] =>[orig_patent_app_number] => 10537545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7446860 [patent_doc_number] => 20040186057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Synthetic single domain polypeptides mimicking apolipoprotein E and methods of use' [patent_app_type] => new [patent_app_number] => 10/712447 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17013 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20040186057.pdf [firstpage_image] =>[orig_patent_app_number] => 10712447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 270359 [patent_doc_number] => 07563595 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Nucleic acids encoding functional splice variants of the α7 nicotinic acetylcholine receptor subunit and methods for producing the encoded proteins' [patent_app_type] => utility [patent_app_number] => 10/703953 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 19326 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563595.pdf [firstpage_image] =>[orig_patent_app_number] => 10703953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7149832 [patent_doc_number] => 20040171085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Methods and compositions for treating neurodegenerative diseases' [patent_app_type] => new [patent_app_number] => 10/701919 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10233 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171085.pdf [firstpage_image] =>[orig_patent_app_number] => 10701919 [rel_patent_id] =>[rel_patent_doc_number] =>)